Rui Wang

Associate Professor





Nguyen DD, Gao K, Chen J, Wang R, Wei GW. (2020). Potentially highly potent drugs for 2019-nCoV. bioRxiv : the preprint server for biology

Ogburn EL, Bierer BE, Brookmeyer R, Choirat C, Dean NE, De Gruttola V, Ellenberg SS, Halloran ME, Hanley DF Jr., Lee JK, Wang R, Scharfstein DO. (2020). Aggregating data from COVID-19 trials. Science (New York, N.Y.), 368(6496)

Caroff DA, Wang R, Zhang Z, Wolf R, Septimus E, Harris AD, Jackson SS, Poland RE, Hickok J, Huang SS, Platt R. (2020). The Limited Utility of Ranking Hospitals Based on Their Colon Surgery Infection Rates. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Dean NE, Gsell PS, Brookmeyer R, Crawford FW, Donnelly CA, Ellenberg SS, Fleming TR, Halloran ME, Horby P, Jaki T, Krause PR, Longini IM, Mulangu S, Muyembe-Tamfum JJ, Nason MC, Smith PG, Wang R, Henao-Restrepo AM, De Gruttola V. (2020). Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks. The New England journal of medicine, 382(14)

Nguyen Duc, Gao Kaifu, Chen Jiahui, Wang Rui, Wei Guewei. (2020). Potentially highly potent drugs for 2019-nCoV. Cold Spring Harbor Laboratory

Wirth KE, Gaolathe T, Pretorius Holme M, Mmalane M, Kadima E, Chakalisa U, Manyake K, Matildah Mbikiwa A, Simon SV, Letlhogile R, Mukokomani K, van Widenfelt E, Moyo S, Bennett K, Leidner J, Powis KM, Lebelonyane R, Alwano MG, Jarvis J, Dryden-Peterson SL, Kgathi C, Moore J, Bachanas P, Raizes E, Abrams W, Block L, Sento B, Novitsky V, El-Halabi S, Marukutira T, Mills LA, Sexton C, Pals S, Shapiro RL, Wang R, Lei Q, DeGruttola V, Makhema J, Essex M, Lockman S, Tchetgen Tchetgen EJ. (2020). Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial. The lancet. HIV, 7(6)

Nguyen Duc Duy, Gao Kaifu, Wang Rui, Wei Guowei. (2020). Machine intelligence design of 2019-nCoV drugs

Rhee C, Li Z, Wang R, Song Y, Kadri SS, Septimus EJ, Chen HC, Fram D, Jin R, Poland R, Sands K, Klompas M. (2020). Impact of Risk Adjustment Using Clinical vs Administrative Data on Hospital Sepsis Mortality Comparisons. Open forum infectious diseases, 7(6)

Li Qun, Guan Xuhua, Wu Peng, Wang Xiaoye, Zhou Lei, Tong Yeqing, Ren Ruiqi, Leung Kathy S M, Lau Eric H Y, Wong Jessica Y., Xing Xuesen, Xiang Nijuan, Wu Yang, Li Chao, Chen Qi, Li Dan, Liu Tian, Zhao Jing, Li Man, Tu Wenxiao, Chen Chuding, Jin Lianmei, Yang Rui, Wang Qi, Zhou Suhua, Wang Rui, Liu Hui, Luo Yingbo, Liu Yuan, Shao Ge, Li Huan, Tao Zhongfa, Yang Yang, Deng Zhiqiang, Liu Boxi, Ma Zhitao, Zhang Yanping, Shi Guoqing, Lam Tommy T Y, Wu Joseph T K, Gao George F., Cowling Benjamin J., Yang Bo, Leung Gabriel M., Feng Zijian. (2020). Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Kim JS, Azarbarzin A, Wang R, Djonlagic IE, Punjabi NM, Zee PC, Koo BB, Soliman EZ, Younes M, Redline S. (2020). Association of novel measures of sleep disturbances with blood pressure: the Multi-Ethnic Study of Atherosclerosis. Thorax, 75(1)

Harrison LJ, Chen T, Wang R. (2019). Power calculation for cross-sectional stepped wedge cluster randomized trials with variable cluster sizes. Biometrics

Xu Y, Laeyendecker O, Wang R. (2019). Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities. Biometrics, 75(3)

Rhee C, Wang R, Song Y, Zhang Z, Kadri SS, Septimus EJ, Fram D, Jin R, Poland RE, Hickok J, Sands K, Klompas M. (2019). Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data. Critical care explorations, 1(10)

Kahn R, Hitchings M, Wang R, Bellan SE, Lipsitch M. (2019). Analyzing Vaccine Trials in Epidemics With Mild and Asymptomatic Infection. American journal of epidemiology, 188(2)

Hitchings MDT, Lipsitch M, Wang R, Bellan SE. (2018). Competing Effects of Indirect Protection and Clustering on the Power of Cluster-Randomized Controlled Vaccine Trials. American journal of epidemiology, 187(8)

Wang R, De Gruttola V. (2017). The use of permutation tests for the analysis of parallel and stepped-wedge cluster-randomized trials. Statistics in medicine, 36(18)

Wang R, Dong Y, Weng J, Kontos EZ, Chervin RD, Rosen CL, Marcus CL, Redline S. (2017). Associations among Neighborhood, Race, and Sleep Apnea Severity in Children. A Six-City Analysis. Annals of the American Thoracic Society, 14(1)

Patel SR, Weng J, Rueschman M, Dudley KA, Loredo JS, Mossavar-Rahmani Y, Ramirez M, Ramos AR, Reid K, Seiger AN, Sotres-Alvarez D, Zee PC, Wang R. (2015). Reproducibility of a Standardized Actigraphy Scoring Algorithm for Sleep in a US Hispanic/Latino Population. Sleep, 38(9)

Wang R, Schoenfeld DA, Hoeppner B, Evins AE. (2015). Detecting treatment-covariate interactions using permutation methods. Statistics in medicine, 34(12)

Wang R, Goyal R, Lei Q, Essex M, De Gruttola V. (2014). Sample size considerations in the design of cluster randomized trials of combination HIV prevention. Clinical trials (London, England), 11(3)

Wang R, Weng J, Moyo S, Pain D, Barr CD, Maruapula D, Mongwato D, Makhema J, Novitsky V, Essex M. (2013). Short communication: effect of short-course antenatal zidovudine and single-dose nevirapine on the BED capture enzyme immunoassay levels in HIV type 1 subtype C infection. AIDS research and human retroviruses, 29(6)

Novitsky V, Wang R, Rossenkhan R, Moyo S, Essex M. (2013). Intra-host evolutionary rates in HIV-1C env and gag during primary infection. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, (19)

Wang R, Bosch RJ, Benson CA, Lederman MM. (2012). Drug-resistant virus has reduced ability to induce immune activation. Journal of acquired immune deficiency syndromes (1999), 61(4)

Claggett B, Lagakos SW, Wang R. (2012). Augmented cross-sectional studies with abbreviated follow-up for estimating HIV incidence. Biometrics, 68(1)

Wang R, Ware JH. (2013). Detecting moderator effects using subgroup analyses. Prevention science : the official journal of the Society for Prevention Research, 14(2)

Novitsky V, Wang R, Margolin L, Baca J, Rossenkhan R, Moyo S, van Widenfelt E, Essex M. (2011). Transmission of single and multiple viral variants in primary HIV-1 subtype C infection. PloS one, 6(2)

Wang R, Lagakos SW, Gray RJ. (2010). Testing and interval estimation for two-sample survival comparisons with small sample sizes and unequal censoring. Biostatistics (Oxford, England), 11(4)


Wang R, Lagakos SW. (2010). Augmented cross-sectional prevalence testing for estimating HIV incidence. Biometrics, 66(3)

Novitsky V, Wang R, Kebaabetswe L, Greenwald J, Rossenkhan R, Moyo S, Musonda R, Woldegabriel E, Lagakos S, Essex M. (2009). Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection. Journal of acquired immune deficiency syndromes (1999), 52(2)

Novitsky V, Wang R, Margolin L, Baca J, Kebaabetswe L, Rossenkhan R, Bonney C, Herzig M, Nkwe D, Moyo S, Musonda R, Woldegabriel E, van Widenfelt E, Makhema J, Lagakos S, Essex M. (2009). Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infection. PloS one, 4(11)

Wang R, Lagakos SW. (2009). On the use of adjusted cross-sectional estimators of HIV incidence. Journal of acquired immune deficiency syndromes (1999), 52(5)

Wang R, Lagakos SW. (2009). Inference after variable selection using restricted permutation methods. The Canadian journal of statistics = Revue canadienne de statistique, 37(4)

Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. (2007). Statistics in medicine--reporting of subgroup analyses in clinical trials. The New England journal of medicine, 357(21)